Changes and complication rate in surgery for thoracic esophageal carcinoma;Veränderungen und komplikationsrate in der chirurgie des thorakalen ösophaguskarzinoms

Zentralblatt fur Chirurgie

Volumn 128, Issue 8, 2003, Pages 631-639

  Meyer, Thomas ^a   Merkel, S ^a   Gohl J ^a   Stumpf, P ^a   Hohenberger, W ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Complication rate; Esophageal carcinoma; Mortality; Surgery; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; SQUAMOUS CELL CARCINOMA; STANDARDIZATION; SURGICAL TECHNIQUE; TUMOR LOCALIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; TIME FACTORS;

EID: 0042331607     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-41371     Document Type: Article

References (44)

1. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994; 220: 364-372
2. Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M. Improvement in the results of surgical treatment of advanced esophageal carcinoma during 15 consecutive years. Ann Surg 2000; 232: 225-232
3. Baba M, Aikou T, Yoshinaka H, Natsugoe S, Fukumoto T, Shimazu H, Akazawa K. Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg 1994; 210: 310-316
4. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346: 1128-1137
5. Blom D, Peters JH. Surgery, radiotherapy, and chemotherapy in carcinoma of the esophagus. Curr Opin Gastroenterol 2000; 16: 392-399
6. Blot JW. Esophageal cancer trend and risk factors. Semin Oncol 1994; 21: 403-410
7. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, Lozach P, Ollier JC, Pavy JJ, Mercier M, Sahmoud T. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997; 337: 161-167
8. Brücher BL, Weber E, Bauer M, Fink U, Avril N, Stein HJ, Werner M, Zimmerman F, Siewert JR, Schwaiger M. Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg 2001; 233: 300-309
9. Chidel MA, Rice TW, Adelstein DJ, Kupelian PA, Suh JH, Becker M. Resectable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy. Radiology 1999; 213: 67-72
10. Chu KM, Law SYK, Fok M, Wong J. A prospective randomized comparison of transhiatial and transthoracic resection for lower-third esophageal carcinoma. Am J Surg 1997; 174: 320-324
11. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: a critial review of surgery. Br J Surg 1980; 67: 381-390
12. Fok M, Law S, Stipa F, Cheng SW, Wong J. A comparison of transhiatal and transthoracic resection for oesophageal carcinoma. Endoscopy 1993; 25: 660-663
13. Fink U, Stein HJ, Wilke H, Roder HD, Siewert JR. Multimodale Behandlung des Plattenepithelkarzinoms des Ösophagus. World J Surg 1995; 19: 198-204
14. Goldmine M, Maddern G, LePrise E, Meunier B. Oesophagectomy by a transhiatal approach or thoracotomy: a prospective randomized trial. Br J Surg 1993; 80: 367-370
15. Hölscher AH. Ösophaguskarzinom - Operative Therapie in Zentren. Dt Ärzteblatt 2001; 98: B1624-1627
16. Hölscher AH, Dittler HJ, Siewert JR. Staging of squamous esophageal cancer: accuracy and value. World J Surg 1994; 18: 312-320
17. Hulscher JB, Tijssen JG, Obertop H, van Lanschot JJ. Transthoracic versus transhiatial resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg 2001; 72: 306-313
18. Kok TC, van Lanschot J, Siersema PD, von Overhagen H, Tilanus HW. Neoadjuvant chemotherapy in operable squamous cell cancer: final report of a phase III multicenter randomised trial. Proc Am Soc Clin Oncol 1997; 17: 984
19. Kolh P, Honore P, Degauque C, Gielen JL, Gerard P, Jacquet N. Early stage results after oesophageal resection for malignancy - colon interposition vs. gastric pull-up. Eur J Cardiothoracic Surg 2000; 18: 293-300
20. Kurzgefasste Interdisziplinäre Leitlinien der Deutschen Krebsgesellschaft. Ösophaguskarzinom (D1). W. Zuckschwerdt Verlag, München, Bern, Wien, New York 2002; 145
21. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-831
22. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999; 130: 883-890
23. McManus K, Anikin V, McGuigan. Total thoracic oesophagectomy for oesophageal carcinoma: has it been worth it? Eur J Cardiothoracic Surg 1999; 16: 261-265
24. Matthews HR, Powell DJ, Mc Conkey CC. Effect of surgical experience on the results of resection for oesophageal carcinoma. Br J Surg 1986; 73: 621-623
25. Miller JD, Jain MK, de-Gara CJ, Morgan D, Urschel JD. Effect of surgical experience on results of esophagectomy for esophageal carcinoma. J Surg Oncol 1997; 65: 20-21
26. Müller JM, Erasmi H, Stelzner M, Zieren U, Pichmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845-857
27. Naunheim KS, Petruska P, Roy TS, Andrus CH, Johnson FE, Schlueter JM, Baue AE. Preoperative chemotherapy and radiotherapy for esophageal carcinoma. J Thorac Cardiovasc Surg 1992; 103: 887-895
28. Nishihira T, Hirayama K, Mori S. A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 1998; 175: 47-51
29. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A, Nidntyla M, Modig H, Munck-WiMand E, Rosengren B, Tausjo J, Elgen K. Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy: the second Scandinavian trial in esophageal cancer. World J Surg 1992; 16: 1104-1110
30. O'Reilly S, Forastiere A. New approaches to treating oesophageal cancer. BMJ 1994; 14: 1249-1250
31. Orringer MB, Marshall B, Sterling MC. Transhiatal esophagectomy for benign and malignant disease. J Thorac Cardiovasc Surg 1993; 105: 265-276
32. Patti MG, Corvera CU, Glasgow RE, Way LW. A hospital's annual rate of esophagectomy influences the operative mortality. J Gastrointest Surg 1998; 2: 186-192
33. Pommier RF, Vetto JT, Ferris BL, Wilmarth TJ. Relationships between operative approaches and outcomes in esophageal surgery. Am J Surg 1998; 175: 422-425
34. Poon RT, Law SY, Chu KM, Branicki FJ, Wong J. Esophagectomy for carcinoma of the esophagus in the elderly: results of current surgical mangement. Ann Surg 1998; 224: 357-364
35. Putnam JB, Svell DM, Mc Murktrey MJ, Ryan B, Walsh GL, Natarajan G, Roth JA. Comparison of three techniques of esophagectomy within a residency training program. Ann Thoracic Surg 1994; 57: 319-325
36. Reed CE. Surgical Management of Esophageal Cancer. Oncologist 1999; 4: 95-105
37. Sharma P, Sampliner RE. Barrett esophagus. Curr Opin Gastroenterol 2000; 16: 374-379
38. Siewert JR, Stein HJ, Feith M, Brücher BL, Bartels H, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western World. Ann Surg 2001; 234: 360-367
39. Siewert JR, Ott K. Multimodale Therapiekonzepte beim Ö sophaguskarzinom. Kongressbd Dtsch Ges Chir Kongr 2001; 118: 39-43
40. Siewert JR, Stein HJ. Lymph-node dissection in squamous cell esophageal cancer - who benefits? Langenbecks Arch Surg 1999; 384: 141-148
41. th edition. John Wiley & Sons, New York 1997
42. Swisher SG, DeFord J, Merriman KW, Walsh GL, Smythe R, Vaporicyan A, Ajanai JA, Brown T, Komaki R, Roth JA, Putnam JB. Effect of operative volume on morbidity, mortality and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 2000; 119: 1126-1134
43. Van Lanschot JJB, Hulscher JFB, Buskens CJ, Tilanus HW, Ten Kate FJW, Obertop H. Hospital volume and hospital mortality for esophagectomy. Cancer 2001; 91: 1574-1578
44. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy T. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-467